InMed Pharmaceuticals Inc. | Business Contracts

Registration Rights Agreement (Filed With SEC on November 22, 2022)

Form of Placement Agent Preferred Investment Option (Filed With SEC on November 22, 2022)

Employment Agreement dated July 15, 2022, between InMed Pharmaceuticals Inc. and Michael Woudenberg (Filed With SEC on July 20, 2022)

Amended and Restated Agreement and Plan of Reorganization, dated as of October 13, 2021, by and among InMed Pharmaceuticals Inc., BayMedica, LLC, BayMedica, Inc., BM REP, LLC, as... (Filed With SEC on October 13, 2021)

Form of InMed Pharmaceuticals Inc. Indemnification Agreement entered into with each member of the board of directors and Chief Financial Officer (Filed With SEC on September 24, 2021)

Office Premises Lease, dated January 14, 2019, between InMed Pharmaceuticals Inc. and 815 West Hastings Ltd (Filed With SEC on June 19, 2020)

Form of Securities Purchase Agreement (Filed With SEC on November 22, 2022)

Form of Preferred Investment Option (Filed With SEC on November 22, 2022)

Form of Pre-Funded Warrant (Filed With SEC on November 22, 2022)

Form of Registration Rights Agreement (Filed With SEC on September 14, 2022)

Form of Securities Purchase Agreement (Filed With SEC on September 14, 2022)

Form of Placement Agent Preferred Investment Option (Filed With SEC on September 14, 2022)

Form of Preferred Investment Option (Filed With SEC on September 14, 2022)

Form of Pre-Funded Warrant (Filed With SEC on September 14, 2022)

Amendment dated July 11, 2022 to Eric Adams Employment Agreement dated 1 March 2021 (Filed With SEC on July 18, 2022)

Form of Pre-Funded Warrant (Filed With SEC on June 6, 2022)

Form of Preferred Investment Option (Filed With SEC on June 6, 2022)

Form of Pre-Funded Warrant (Filed With SEC on June 6, 2022)

Warrant Amendment Agreement (Filed With SEC on June 6, 2022)

Form of Securities Purchase Agreement (Filed With SEC on June 6, 2022)

Registration Rights Agreement (Filed With SEC on June 6, 2022)

At the Market Offering Agreement dated April 7, 2021 by and between InMed Pharmaceuticals Inc., and H.C. Wainwright & Co., LLC (Filed With SEC on April 7, 2022)

Form of Amendment of Purchase Agreement and Common Stock Purchase Warrant, dated March 21, 2022 (Filed With SEC on March 22, 2022)

Form of Series B Warrant (to be issued pursuant to the Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC,... (Filed With SEC on September 24, 2021)

Form of Series A Warrant (to be issued pursuant to the Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC,... (Filed With SEC on September 24, 2021)

Agreement and Plan of Reorganization, dated as of September 10, 2021, by and among InMed Pharmaceuticals Inc., InMed LLC, BayMedica, Inc., BM REP, LLC, as the stockholder... (Filed With SEC on September 24, 2021)

Form of Specific Common Share Certificate (Filed With SEC on July 13, 2021)

Amended and Restated Executive Employment Agreement, dated March 1, 2021, between Bruce S. Colwill and InMed Pharmaceuticals Inc (Filed With SEC on July 13, 2021)

Amended and Restated Executive Employment Agreement, dated March 1, 2021, between Michael Woudenberg and InMed Pharmaceuticals Inc (Filed With SEC on July 13, 2021)

Amended and Restated Executive Employment Agreement, dated March 1, 2021, between Alexandra Mancini and InMed Pharmaceuticals Inc (Filed With SEC on July 13, 2021)

Amended and Restated Executive Employment Agreement, dated March 1, 2021, between Eric Hsu and InMed Pharmaceuticals Inc (Filed With SEC on July 13, 2021)

Amended and Restated Executive Employment Agreement, dated March 1, 2021, between Eric A. Adams and InMed Pharmaceuticals Inc (Filed With SEC on July 13, 2021)

Form of Registration Rights Agreement (Filed With SEC on June 30, 2021)

Form of Securities Purchase Agreement (Filed With SEC on June 30, 2021)

Form of Pre-Funded Warrant (Filed With SEC on June 30, 2021)

Form of Series A Warrant (Filed With SEC on June 30, 2021)

Form of Registration Rights Agreement (Filed With SEC on February 5, 2021)

Form of Securities Purchase Agreement (Filed With SEC on February 5, 2021)

Placement Agency Agreement, dated February 5, 2021 (Filed With SEC on February 5, 2021)

Form of Common Share Purchase Warrant (Filed With SEC on February 5, 2021)

Form of Public Warrant (Filed With SEC on November 12, 2020)

Underwriting Agreement, dated November 12, 2020, by and between InMed Pharmaceuticals Inc. and Roth Capital Partners, LLC, as representative of the underwriters named therein (Filed With SEC on November 12, 2020)

Form of Public Warrant (Filed With SEC on October 8, 2020)

Form of Pre-Funded Warrant (Filed With SEC on October 8, 2020)

Form of Underwriting Agreement (Filed With SEC on September 15, 2020)

July 3, 2019 salary adjustment letter to Eric Hsu (Filed With SEC on July 6, 2020)

July 3, 2019 salary adjustment letter to Michael Woudenberg (Filed With SEC on July 6, 2020)

Form of Underwriting Agreement (Filed With SEC on July 6, 2020)

Amendment No. 1 to Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

September 1, 2018 salary adjustment letter to Eric Hsu (Filed With SEC on June 19, 2020)

Amended and Restated Collaborative Research Agreement, dated as of August 16, 2018, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)

Form of Stock Option Agreement pursuant to the InMed Pharmaceuticals Inc. 2017 Stock Option Plan (Filed With SEC on June 19, 2020)

Amended and Restated Executive Employment Agreement, dated April 8, 2020, between Eric A. Adams and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Employment Agreement, dated March 8, 2018, between Eric Hsu and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

April 13, 2018 salary adjustment letter to Eric Hsu (Filed With SEC on June 19, 2020)

March 4, 2019 salary adjustment letter to Eric Hsu (Filed With SEC on June 19, 2020)

Collaborative Research Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Amended and Restated Executive Employment Agreement, dated April 8, 2020, between Alexandra Mancini and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Executive Employment Agreement, dated September 20, 2018, between Michael Woudenberg and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Executive Employment Agreement, dated July 9, 2019, between Bruce S. Colwill and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Share Purchase Agreement, dated May 10, 2014, among Meridex Software Corporation, Biogen Sciences Inc. and the Shareholders of Biogen Sciences Inc (Filed With SEC on June 19, 2020)

Section 85 Purchase and Sale Agreement, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Assignment of Intellectual Property, dated as of October 28, 2015, between Dr. Sazzad Hossain and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

Technology Assignment Agreement, dated as of May 31, 2017, between The University of British Columbia and InMed Pharmaceuticals Inc (Filed With SEC on June 19, 2020)

InMed Pharmaceuticals Inc. (66)